Search results
Raleigh Capital Management Inc. Has $2.67 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoRaleigh Capital Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure ...
Amneal’s IPX-203 shows promising results for motor fluctuations in Parkinson’s disease
Clinical Trials Arena via Yahoo Finance· 4 hours agoFurthermore, there are two novel levodopa delivery systems in Phase III development for PD that are...
Scarborough Advisors LLC Takes $1.38 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoScarborough Advisors LLC bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 8,907 shares of ...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 5 days agoAbbVie is graded C on this front, indicating that it is trading at par with its peers. Click here to...
Security National Bank of SO Dak Purchases 102 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoSecurity National Bank of SO Dak lifted its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 4th quarter, according to the company in its most recent Form ...
State Farm Mutual Automobile Insurance Co. Has $961.26 Million Stock Holdings in AbbVie Inc....
ETF DAILY NEWS· 5 days agoState Farm Mutual Automobile Insurance Co. decreased its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the 4th quarter, according to the company in its ...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 3 days agoIn June 2024 AbbVie announced that its RINVOQ (upadacitinib) is now indicated for treating...
CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and...
Morningstar· 6 days agoLeading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If you invested in Cerevel ...